简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2015-05-05 14:06 Quintiles Establishes Bioanalytical Laboratory in Europe
2015-05-04 17:49 Quintiles Named to InformationWeek Elite 100
2015-05-04 15:24 Arcadia Biosciences, Inc. Commences Initial Public Offering
2015-05-04 15:07 Teva Sends Letter to Mylan Board
2015-05-04 08:00 GeneronReceived US FDA Clearance to InitiatePhase IIaStudy with F-652, a First-in-Class Biologic, to Treat Patients with Acute GvHD
2015-04-29 13:57 Toshiba Launches Application Processor Development Platforms for Wearable and IoT Devices
2015-04-28 15:54 Teva Reiterates Commitment to Cash-and-Stock Acquisition of Mylan for $82.00 Per Share
2015-04-28 13:52 ElectroCore’s non-invasive vagus nerve stimulation therapy shown to be safe and to produce no meaningful cardiac adverse effects
2015-04-27 15:16 Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and Stock
2015-04-27 15:10 Jean Boulle Group Announces First US Clinical Trial
2015-04-24 10:11 4SC Signs Licensing and Development Agreement with Menarini for Resminostat in Asia-Pacific Excluding Japan
2015-04-23 13:58 Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan
2015-04-22 10:03 Global Trials Show Addition of Medtronic’s Solitaire™ Device Stent Thrombectomy Procedure in Treatment of Acute Ischemic Stroke Improves Neurological Outcomes
2015-04-21 10:59 Kunming Biomed and BTS Research Announce Collaboration at ChinaBio® Partnering Forum in Shanghai
2015-04-17 14:18 Quintiles and Hospital Italiano of Buenos Aires Announce Agreement to Accelerate Clinical Development
2015-04-16 14:37 Study Shows Nitrogen Use Efficiency Trait Increases Biomass of Sugarcane
2015-04-16 10:05 PerkinElmer Launches First Fully Automated Genetic Disorder Screening System in China
2015-04-15 14:11 IncellDx, Inc. Signs Exclusive License with Claremont BioSolutions to Commercialize Novel Liquid-Based Biopsy Technology
2015-04-14 18:00 WIN Consortium Appoints Professor Waun Ki Hong as Special Advisor to Oversee Its Combined Targeted Triple-Therapy Strategy Aiming to Achieve Significant Impact on Survival in Metastatic Lung Cancer
2015-04-10 18:00 Replicor to Present at the 2015 Lancet Viral Hepatitis Conference

Business Wire Weibo

Press Releases

Latest Releases